2018-2023 Global Buprenorphine Hydrochloride Consumption Market Report

August 2018 | 161 pages | ID: 2237D5A7177EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Buprenorphine Hydrochloride market for 2018-2023.

Buprenorphine hydrochloride, a white crystalline powder, is a semisynthetic opioid analgesic used for the relief of moderate to severe pain. It is in the same chemical family of morphine, codeine and heroin. However, buprenorphine hydrochloride has the distinction of producing less euphoric effects than those drugs.
USA is the dominate consumer in buprenorphine hydrochloride industry. The sales volume of USA was 5312 kg in 2015, occupied about 48.11% of the total amount. Europe is the second one, with the sales volume of 4222 kg, and the sales market share of 38.24% in 2015.
Over the next five years, LPI(LP Information) projects that Buprenorphine Hydrochloride will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares, and growth opportunities of Buprenorphine Hydrochloride market by product type, application, key manufacturers and key regions.

To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

Segmentation by product type:

• Type I
• Type II

Segmentation by application:

• Analgesic
• Opioid Antagonist

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:

• Siegfried
• Sanofi
• Johnson Matthey
• Mallinckrodt
• Noramco
• Unichemlabs
• Arevipharma
• Resonance-labs
• Sun Pharma
• Rusan Pharma
• Micro Orgo Chem
• Faranshimi

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

• To study and analyze the global Buprenorphine Hydrochloride consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
• To understand the structure of Buprenorphine Hydrochloride market by identifying its various subsegments.
• Focuses on the key global Buprenorphine Hydrochloride manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Buprenorphine Hydrochloride with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the consumption of Buprenorphine Hydrochloride submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Buprenorphine Hydrochloride Consumption 2013-2023
  2.1.2 Buprenorphine Hydrochloride Consumption CAGR by Region
2.2 Buprenorphine Hydrochloride Segment by Type
  2.2.1 Type I
  2.2.2 Type II
2.3 Buprenorphine Hydrochloride Consumption by Type
  2.3.1 Global Buprenorphine Hydrochloride Consumption Market Share by Type (2013-2018)
  2.3.2 Global Buprenorphine Hydrochloride Revenue and Market Share by Type (2013-2018)
  2.3.3 Global Buprenorphine Hydrochloride Sale Price by Type (2013-2018)
2.4 Buprenorphine Hydrochloride Segment by Application
  2.4.1 Analgesic
  2.4.2 Opioid Antagonist
2.5 Buprenorphine Hydrochloride Consumption by Application
  2.5.1 Global Buprenorphine Hydrochloride Consumption Market Share by Application (2013-2018)
  2.5.2 Global Buprenorphine Hydrochloride Value and Market Share by Application (2013-2018)
  2.5.3 Global Buprenorphine Hydrochloride Sale Price by Application (2013-2018)

3 GLOBAL BUPRENORPHINE HYDROCHLORIDE BY PLAYERS

3.1 Global Buprenorphine Hydrochloride Sales Market Share by Players
  3.1.1 Global Buprenorphine Hydrochloride Sales by Players (2016-2018)
  3.1.2 Global Buprenorphine Hydrochloride Sales Market Share by Players (2016-2018)
3.2 Global Buprenorphine Hydrochloride Revenue Market Share by Players
  3.2.1 Global Buprenorphine Hydrochloride Revenue by Players (2016-2018)
  3.2.2 Global Buprenorphine Hydrochloride Revenue Market Share by Players (2016-2018)
3.3 Global Buprenorphine Hydrochloride Sale Price by Players
3.4 Global Buprenorphine Hydrochloride Manufacturing Base Distribution, Sales Area, Product Types by Players
  3.4.1 Global Buprenorphine Hydrochloride Manufacturing Base Distribution and Sales Area by Players
  3.4.2 Players Buprenorphine Hydrochloride Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 BUPRENORPHINE HYDROCHLORIDE BY REGIONS

4.1 Buprenorphine Hydrochloride by Regions
  4.1.1 Global Buprenorphine Hydrochloride Consumption by Regions
  4.1.2 Global Buprenorphine Hydrochloride Value by Regions
4.2 Americas Buprenorphine Hydrochloride Consumption Growth
4.3 APAC Buprenorphine Hydrochloride Consumption Growth
4.4 Europe Buprenorphine Hydrochloride Consumption Growth
4.5 Middle East & Africa Buprenorphine Hydrochloride Consumption Growth

5 AMERICAS

5.1 Americas Buprenorphine Hydrochloride Consumption by Countries
  5.1.1 Americas Buprenorphine Hydrochloride Consumption by Countries (2013-2018)
  5.1.2 Americas Buprenorphine Hydrochloride Value by Countries (2013-2018)
5.2 Americas Buprenorphine Hydrochloride Consumption by Type
5.3 Americas Buprenorphine Hydrochloride Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Buprenorphine Hydrochloride Consumption by Countries
  6.1.1 APAC Buprenorphine Hydrochloride Consumption by Countries (2013-2018)
  6.1.2 APAC Buprenorphine Hydrochloride Value by Countries (2013-2018)
6.2 APAC Buprenorphine Hydrochloride Consumption by Type
6.3 APAC Buprenorphine Hydrochloride Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Buprenorphine Hydrochloride by Countries
  7.1.1 Europe Buprenorphine Hydrochloride Consumption by Countries (2013-2018)
  7.1.2 Europe Buprenorphine Hydrochloride Value by Countries (2013-2018)
7.2 Europe Buprenorphine Hydrochloride Consumption by Type
7.3 Europe Buprenorphine Hydrochloride Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Buprenorphine Hydrochloride by Countries
  8.1.1 Middle East & Africa Buprenorphine Hydrochloride Consumption by Countries (2013-2018)
  8.1.2 Middle East & Africa Buprenorphine Hydrochloride Value by Countries (2013-2018)
8.2 Middle East & Africa Buprenorphine Hydrochloride Consumption by Type
8.3 Middle East & Africa Buprenorphine Hydrochloride Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 MARKETING, DISTRIBUTORS AND CUSTOMER

10.1 Sales Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
10.2 Buprenorphine Hydrochloride Distributors
10.3 Buprenorphine Hydrochloride Customer

11 GLOBAL BUPRENORPHINE HYDROCHLORIDE MARKET FORECAST

11.1 Global Buprenorphine Hydrochloride Consumption Forecast (2018-2023)
11.2 Global Buprenorphine Hydrochloride Forecast by Regions
  11.2.1 Global Buprenorphine Hydrochloride Forecast by Regions (2018-2023)
  11.2.2 Global Buprenorphine Hydrochloride Value Forecast by Regions (2018-2023)
  11.2.3 Americas Consumption Forecast
  11.2.4 APAC Consumption Forecast
  11.2.5 Europe Consumption Forecast
  11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
  11.3.1 United States Market Forecast
  11.3.2 Canada Market Forecast
  11.3.3 Mexico Market Forecast
  11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
  11.4.1 China Market Forecast
  11.4.2 Japan Market Forecast
  11.4.3 Korea Market Forecast
  11.4.4 Southeast Asia Market Forecast
  11.4.5 India Market Forecast
  11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
  11.5.1 Germany Market Forecast
  11.5.2 France Market Forecast
  11.5.3 UK Market Forecast
  11.5.4 Italy Market Forecast
  11.5.5 Russia Market Forecast
  11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
  11.6.1 Egypt Market Forecast
  11.6.2 South Africa Market Forecast
  11.6.3 Israel Market Forecast
  11.6.4 Turkey Market Forecast
  11.6.5 GCC Countries Market Forecast
11.7 Global Buprenorphine Hydrochloride Forecast by Type
11.8 Global Buprenorphine Hydrochloride Forecast by Application

12 KEY PLAYERS ANALYSIS

12.1 Siegfried
  12.1.1 Company Details
  12.1.2 Buprenorphine Hydrochloride Product Offered
  12.1.3 Siegfried Buprenorphine Hydrochloride Sales, Revenue, Price and Gross Margin (2016-2018)
  12.1.4 Main Business Overview
  12.1.5 Siegfried News
12.2 Sanofi
  12.2.1 Company Details
  12.2.2 Buprenorphine Hydrochloride Product Offered
  12.2.3 Sanofi Buprenorphine Hydrochloride Sales, Revenue, Price and Gross Margin (2016-2018)
  12.2.4 Main Business Overview
  12.2.5 Sanofi News
12.3 Johnson Matthey
  12.3.1 Company Details
  12.3.2 Buprenorphine Hydrochloride Product Offered
  12.3.3 Johnson Matthey Buprenorphine Hydrochloride Sales, Revenue, Price and Gross Margin (2016-2018)
  12.3.4 Main Business Overview
  12.3.5 Johnson Matthey News
12.4 Mallinckrodt
  12.4.1 Company Details
  12.4.2 Buprenorphine Hydrochloride Product Offered
  12.4.3 Mallinckrodt Buprenorphine Hydrochloride Sales, Revenue, Price and Gross Margin (2016-2018)
  12.4.4 Main Business Overview
  12.4.5 Mallinckrodt News
12.5 Noramco
  12.5.1 Company Details
  12.5.2 Buprenorphine Hydrochloride Product Offered
  12.5.3 Noramco Buprenorphine Hydrochloride Sales, Revenue, Price and Gross Margin (2016-2018)
  12.5.4 Main Business Overview
  12.5.5 Noramco News
12.6 Unichemlabs
  12.6.1 Company Details
  12.6.2 Buprenorphine Hydrochloride Product Offered
  12.6.3 Unichemlabs Buprenorphine Hydrochloride Sales, Revenue, Price and Gross Margin (2016-2018)
  12.6.4 Main Business Overview
  12.6.5 Unichemlabs News
12.7 Arevipharma
  12.7.1 Company Details
  12.7.2 Buprenorphine Hydrochloride Product Offered
  12.7.3 Arevipharma Buprenorphine Hydrochloride Sales, Revenue, Price and Gross Margin (2016-2018)
  12.7.4 Main Business Overview
  12.7.5 Arevipharma News
12.8 Resonance-labs
  12.8.1 Company Details
  12.8.2 Buprenorphine Hydrochloride Product Offered
  12.8.3 Resonance-labs Buprenorphine Hydrochloride Sales, Revenue, Price and Gross Margin (2016-2018)
  12.8.4 Main Business Overview
  12.8.5 Resonance-labs News
12.9 Sun Pharma
  12.9.1 Company Details
  12.9.2 Buprenorphine Hydrochloride Product Offered
  12.9.3 Sun Pharma Buprenorphine Hydrochloride Sales, Revenue, Price and Gross Margin (2016-2018)
  12.9.4 Main Business Overview
  12.9.5 Sun Pharma News
12.10 Rusan Pharma
  12.10.1 Company Details
  12.10.2 Buprenorphine Hydrochloride Product Offered
  12.10.3 Rusan Pharma Buprenorphine Hydrochloride Sales, Revenue, Price and Gross Margin (2016-2018)
  12.10.4 Main Business Overview
  12.10.5 Rusan Pharma News
12.11 Micro Orgo Chem
12.12 Faranshimi

13 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Buprenorphine Hydrochloride
Table Product Specifications of Buprenorphine Hydrochloride
Figure Buprenorphine Hydrochloride Report Years Considered
Figure Market Research Methodo